JCR Pharma & Modalis validate initial proof of concept in a joint ...
17 hours ago · JCR Pharmaceuticals Co., Ltd., a global specialty pharmaceuticals company, and Modalis Therapeutics Corporation, a forerunner in the field of epigenetic medicine, announced …
Acurx Pharma receives positive regulatory guidance from EMA for ...
16 hours ago · Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, …
News - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Eton Pharma acquires Galzin, an US FDA approved treatment of …
1 day ago · Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired …
Editorial - Pharmabiz.com
Nov 6, 2024 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic …
India's most comprehensive portal on pharmaceutical News, …
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Frequency: Weekly (Goes into printing every Tuesday; On stands …
Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle …
Annovis Bio gets US FDA clearance to begin pivotal phase 3 …
Oct 17, 2024 · Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing: Malvern, Pennsylvania Thursday, October 17, …
Pharma industry views US FDA guidance on developing drugs for …
Mar 26, 2024 · Pharma industry views US FDA guidance on developing drugs for early Alzheimer’s disease as invaluable: Nandita Vijayasimha, Bengaluru Tuesday, March 26, 2024, …
US FDA clears Tyra Biosciences’ IND application to proceed with …
Oct 29, 2024 · US FDA clears Tyra Biosciences’ IND application to proceed with phase 2 study of TYRA-300 in paediatric achondroplasia: Carlsbad, California Tuesday, October 29, 2024, …